France

National Health Strategy 2018-2022

Executive

Strategy

Passed in 2018

Because of climate change, the strategy calls for 1) a limitation of the risks of endemisation and epidemisation by monitoring and countermeasures adapted to "tropical" pathologies, 2) organise entomological surveillance and prevent the establishment and development of vector mosquitoes, in close collaboration with local authorities, and 3) strengthen the prevention of vector-borne diseases by better informing the public and health professionals, particularly on hygiene measures. A particular focus will have to be performed toward overseas territories.

Documents

Link to full text (PDF) (French)

Climate targets in this law

3 targets

- Promote biosimilar medicines that have the same efficacy, quality and safety as the reference biological medicine, with the objective of reaching 80% penetration of biosimilars in their reference market by 2022.

Health | Target year: 2022
1 prescription in the directory for every 2 prescriptions

Health | Target year: 2020
Reduce antibiotics consumption by 25% by 2020

Health | Target year: 2020